ILLUMINA
| WVB Number : USA000035612 | Country : United States of America |
| SIC categorization : LAB ANALYTICAL INSTRUMENTS (3826) | ISIN : US4523271090 |
| FT categorization : DIV ELECTRONIC & INSTRUMENTS (550) | |
| Company status: ACTIVE |
» Corporation Profile :
| Profile in brief: The Companyare a provider of sequencing- and array-based solutions, serving customers in the research, clinical and applied markets. |
|
| Phone : 1 302 658 7581 | Fax : |
| Chairman: : JOHN WENDELL THOMPSON | Auditor : ERNST & YOUNG LLP |
| CEO/Managing Director : JACOB THAYSEN | |
» Company Facts
| Net Profit Margin (%) | -27.97 |
| Operating Margin (%) | -24.68 |
| Return on Assets (%) | -14.90 |
| Return on Equity (%) | -30.13 |
| Employees | 9,030 |
» Company Financials
| Annual (2024) | |
| Income Statement ('000 USD ) |
|
| Sales/Total Revenue | 4,372,000 |
| EBITDA | 1,407,000 |
| EBIT | -820,000 |
| Net Income | -1,223,000 |
| Balance Sheet ( '000 USD) |
|
| Total Current Assets | 2,746,000 |
| Total Assets | 6,303,000 |
| Current Liabilities | 1,547,000 |
| Total Liabilities & Debt | 3,930,000 |
| Total Equity | 2,373,000 |
| Cash & Flow ( '000 USD) |
|
| Net Income/Staring Line | -1,223,000 |
| Cash from Operating | 837,000 |
| Cash from Investing | -178,000 |
| Cash from Financing | -570,000 |
| Cash & Equivalent Yr End | 1,127,000 |